Hong Kong, China

Wanfei Li

This inventor holds 1 USPTO granted patent. Top assignee: Hong Kong Baptist University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wanfei Li. Retrieved from https://idiyas.com/inventor/wanfei-li-uz3se02x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wanfei Li: Innovator in Antiviral Research

Introduction

Wanfei Li is a prominent inventor based in Hong Kong, China. He has made significant contributions to the field of antiviral research, particularly through his innovative work on patentiflorin A analogs. His research focuses on developing effective antiviral agents that can combat various viral infections.

Latest Patents

Wanfei Li holds 1 patent for his invention titled "Patentiflorin A analogs as antiviral agents." This patent discloses analogs of patentiflorin A that are useful as antivirals, targeting viruses such as HIV, coronaviruses, Ebola, and influenza. The methods of use for these analogs highlight their potential in treating serious viral infections.

Career Highlights

Wanfei Li is affiliated with Hong Kong Baptist University, where he conducts his research and contributes to the academic community. His work has garnered attention for its potential impact on public health, particularly in the development of new antiviral therapies.

Collaborations

Throughout his career, Wanfei Li has collaborated with notable colleagues, including Hongjie Zhang and Nga Yi Tsang. These collaborations have enriched his research and expanded the scope of his work in antiviral development.

Conclusion

Wanfei Li's innovative research in antiviral agents positions him as a key figure in the fight against viral diseases. His contributions to the field are invaluable and hold promise for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…